You are currently viewing a new version of our website. To view the old version click .

Kidney and Dialysis

Kidney and Dialysis is an international, peer-reviewed, open access journal on nephrology and dialysis published quarterly online by MDPI.
The Osaka Society for Dialysis Therapy (OSDT) is affiliated with Kidney and Dialysis and its members receive discounts on the article processing charges.
Quartile Ranking JCR - Q2 (Urology and Nephrology)

All Articles (191)

Background: Gastrointestinal (GI) symptoms are highly prevalent in people receiving dialysis and contribute to malnutrition and poor quality of life. We examined the prevalence and severity of GI symptoms in Jordanian adults with end-stage kidney disease (ESKD) treated with hemodialysis (HD) or peritoneal dialysis (PD). Methods: In this cross-sectional study, consecutive adults with ESKD receiving maintenance HD at Al-Karak Teaching Hospital or PD at Al-Basheer Hospital were interviewed using the validated Arabic Gastrointestinal Symptom Rating Scale (GSRS). Domain and total scores (range 1–7) were compared between modalities; a GSRS total score ≥3 defined at least mild overall GI symptom burden. Results: Among 168 ESKD participants (mean age 43.4 ± 15.3 years; 116 HD, 52 PD), 92.2% reported at least one GI symptom. The prevalence of GSRS-defined symptoms was greater in PD (94.2%) than HD (91.4%). PD was associated with significantly higher mean scores in all GSRS domains (reflux, abdominal pain, indigestion, diarrhea, constipation) and a higher total GSRS score (3.33 ± 1.36 vs. 2.36 ± 0.71; p < 0.01 for all comparisons). Upper GI bleeding (UGIB) requiring hospitalization after dialysis initiation occurred more often in HD than PD (15.5% vs. 3.8%; OR 4.59; 95% CI 1.03–20.58). Conclusions: This study demonstrated that dialysis patients had a high prevalence of GI symptoms, with an elevated severity in patients on PD. These findings highlight the need for routine structured assessment of GI symptoms and modality-specific management strategies in dialysis units, particularly for patients on PD.

22 December 2025

Flowchart of participant selection and inclusion for HD and PD groups.

Membranous Nephropathy: Advances in Diagnosis and Treatment, with an Eye on PLA2R1-Negative Forms

  • Micaela Anna Casiraghi,
  • Anna J. Peired and
  • Adele Mitrotti
  • + 5 authors

Membranous nephropathy (MN) is an immune complexmediated glomerular disease defined by sub-epithelial deposits that trigger complement activation and podocyte injury. Its pathogenesis reflects loss of immune tolerance and may present as a kidney-limited autoimmune process or in association with underlying conditions (e.g., malignancy, infection, drugs, or systemic autoimmunity). Current diagnostic work-up integrates circulating antibodies—most commonly anti–phospholipase A2 receptor 1 (PLA2R1)—and kidney biopsy, which remains essential in PLA2R1-negative or atypical presentations and for antigen confirmation when serology is negative. In PLA2R1-negative MN, an expanding list of antigens is being recognized, potentially refining phenotyping and risk assessment; however, dedicated studies remain limited, and the clinical weight of many newly described antigens likely requires further validation before supporting an antigen-based classification. Uneven access to advanced diagnostics particularly affects PLA2R1-negative cases, underscoring the need for centralized testing and the development of reliable non-invasive biomarkers. Treatment has advanced with rituximab and other targeted therapies, but resistant and relapsing cases remain challenging, and the evidence base for PLA2R1-negative forms is comparatively limited. This review summarizes recent diagnostic and therapeutic advances, focusing on PLA2R1-negative MN.

25 December 2025

Background: Handgrip strength (HGS) is a simple, low-cost indicator of muscle function and predictor of morbidity and mortality in patients with chronic kidney disease (CKD). Objective: To establish sex- and age-specific normative values for HGS in Colombian patients undergoing hemodialysis and to examine its association with clinical and biochemical factors. Methods: A multicenter, cross-sectional study was conducted between August and September 2023 in five cities across Colombia. A total of 436 hemodialysis patients aged 15 to over 80 years were assessed. HGS was measured post-dialysis using a CAMRY EH101 digital dynamometer in both flexion and extension of each arm. The Box–Cox Power Exponential (BCPE) model within the GAMLSS framework was used to generate percentile curves by sex. Comparisons were performed by sex, diabetes status, and occupation. Spearman’s correlation was used to explore associations between HGS and biochemical variables. Results: Males exhibited significantly higher HGS than females (mean difference: 8.09 kg; p < 0.001). Lower HGS was observed among individuals with diabetes and those unemployed. HGS showed a moderate inverse correlation with alkaline phosphatase (r = −0.29, p = 0.0014) and a weak inverse correlation with KT/V (r = −0.22, p = 0.02). No other biochemical markers showed significant associations. Reference percentiles (P3 to P97) were constructed for both sexes. Conclusions: These normative values for HGS represent the first reference standards for Colombian patients on hemodialysis. HGS assessment may support early identification of functional impairment and inform clinical decisions related to rehabilitation and nutritional support.

17 December 2025

We read with great interest the recent paper by Campese (2025) [...]

3 December 2025

News & Conferences

Issues

Open for Submission

Editor's Choice

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Kidney Dial. - ISSN 2673-8236